⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Breckenridge announces launch of Tofacitinib Tablets, generic equivalent of Xeljanz® by Pfizer
prnewswire.com
PFE
Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI
businesswire.com
PFE
MAHA PAC Celebrates Historic Victory as Zach Lahn Wins Iowa Republican Primary for Governor
prnewswire.com
PFE
AlphaSense Raises $350M at $7.5B Valuation, and Surpasses $600M in Annual Recurring Revenue
globenewswire.com
ADBE
AMZN
AXP
CSCO
MSFT
NTAP
NVDA
PFE
CRM
El Meijer LPGA Classic for Simply Give 2026 regresa con las experiencias familiares favoritas de los fanáticos USA - español USA - English
prnewswire.com
V
MSFT
GOOG
AMZN
M
TGT
WMT
KR
COST
PG
JNJ
KO
PEP
MCD
SBUX
DIS
CMCSA
NFLX
AMAT
NVDA
INTC
AMD
QCOM
MU
TXN
ADI
NXPI
MRVL
SNPS
CDNS
ASML
LRCX
KLAC
AMGN
GILD
BMY
PFE
MRK
ABBV
LLY
JPM
BAC
WFC
C
GS
MS
AXP
IBM
ORCL
CRM
CSCO
ACN
ADP
NOW
ADBE
EA
TTWO
CRSP
REGN
VRTX
BIIB
ALGN
EXPE
BKNG
MAR
HPE
DELL
HPQ
AVGO
ADSK
PAYX
FISV
PYPL
MELI
EBAY
BABA
JD
PDD
NIO
XPEV
LI
TSLA
RIVN
LCID
GM
F
STLA
TM
HMC
VWAGY
BBD
AAPL
META
SNAP
PINS
DigiCert Research Reveals Major Certificate Visibility Blind Spot for Enterprises
globenewswire.com
MSFT
GOOG
AMZN
IBM
ORCL
CSCO
DELL
HPQ
INTC
QCOM
NVDA
AMD
AVGO
MU
AMAT
LRCX
KLAC
ADI
TXN
NXPI
MRVL
SNPS
CDNS
ADSK
CRM
ACN
INFY
SAP
PANW
CRWD
OKTA
FTNT
DDOG
NOW
MCHP
ON
LULU
BBY
COST
HD
LOW
TJX
MDT
AMGN
GILD
BMY
PFE
MRK
JNJ
ABBV
LLY
BIIB
REGN
VRTX
AZN
SNOW
SMCI
PLTR
AI
GOOGL
Metastatic HER2-Positive Breast Cancer Market Expected to Surge at a CAGR of 8.3% During the Forecast Period (2026–2036) Due to Advancing Targeted Treatments | DelveInsight
globenewswire.com
PFE
JNJ
AMRX
BOLT
BIIB
Lilly’s Cancer Bombshell Sparks Hunt for the Next Oncology Stock Set to Explode
globenewswire.com
LLY
NTHI
OLMA
PFE
Pfizer’s BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer
businesswire.com
PFE
TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer
businesswire.com
PFE